Default: Human gene therapy methods

ISSN: 1946-6536

Journal Home

Journal Guideline

Human gene therapy methods Q2 Unclaimed

Mary Ann Liebert Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Human gene therapy methods is a journal indexed in SJR in Genetics and Pharmacology with an H index of 35. It has an SJR impact factor of 0,78 and it has a best quartile of Q2. It has an SJR impact factor of 0,78.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Metrics

Human gene therapy methods

0,78

SJR Impact factor

35

H Index

0

Total Docs (Last Year)

24

Total Docs (3 years)

0

Total Refs

88

Total Cites (3 years)

24

Citable Docs (3 years)

0

Cites/Doc (2 years)

0

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope





Best articles by citations

Short-Fiber Protein of Ad40 Confers Enteric Tropism and Protection Against Acidic Gastrointestinal Conditions

View more

AAV2/8 Vectors Purified from Culture Medium with a Simple and Rapid Protocol Transduce Murine Liver, Muscle, and Retina Efficiently

View more

A Quantitative Chloride Channel Conductance Assay for Efficacy Testing of AAV.BEST1

View more

A Systematic Approach to the Establishment and Characterization of Endothelial Progenitor Cells for Gene Therapy

View more

Standard Free Droplet Digital Polymerase Chain Reaction as a New Tool for the Quality Control of High-Capacity Adenoviral Vectors in Small-Scale Preparations

View more

Pokemon siRNA Delivery Mediated by RGD-Modified HBV Core Protein Suppressed the Growth of Hepatocellular Carcinoma

View more

Optimizing Delivery and Expression of Designer Nucleases for Genome Engineering

View more

Spatiotemporal Control of Vascular Endothelial Growth Factor Expression Using a Heat-Shock-Activated, Rapamycin-Dependent Gene Switch

View more

Ex Vivo Generation of Highly Purified and Activated Natural Killer Cells from Human Peripheral Blood

View more

Optimization of Electroporation-Enhanced Intradermal Delivery of DNA Vaccine Using a Minimally Invasive Surface Device

View more

Transduction of the Central Nervous System After Intracerebroventricular Injection of Adeno-Associated Viral Vectors in Neonatal and Juvenile Mice

View more

Suppression of choroidal neovascularization in mice by subretinal delivery of multigenic lentiviral vectors encoding anti-angiogenic microRNAs

View more
SHOW MORE ARTICLES

Function and Safety of Lentivirus-Mediated Gene Transfer for CSF2RA-Deficiency

View more

FDA Statement Regarding the Use of Adeno-Associated Virus Reference Standard Materials

View more

Accurate and Rapid Sequence Analysis of Adeno-Associated Virus Plasmids by Illumina Next-Generation Sequencing

View more

Development of rAAV2-CFTR: History of the First rAAV Vector Product to be Used in Humans

View more

A Novel Method for the Quantification of Adeno-Associated Virus Vectors for RNA Interference Applications Using Quantitative Polymerase Chain Reaction and Purified Genomic Adeno-Associated Virus DNA as a Standard

View more

Robust Lentiviral Gene Delivery But Limited Transduction Capacity of Commonly Used Adeno-Associated Viral Serotypes in Xenotransplanted Human Skin

View more

Tissue-Specific Attenuation of Oncolytic Sindbis Virus Without Compromised Genetic Stability

View more

Locally Targeted Cardiac Gene Delivery by AAV Microbubble Destruction in a Large Animal Model

View more

Efficient Lentiviral Transduction and Transgene Expression in Primary Human B Cells

View more

Inhalation of Nebulized Perfluorochemical Enhances Recombinant Adenovirus and Adeno-Associated Virus-Mediated Gene Expression in Lung Epithelium

View more

Extensive Replication of a Retroviral Replicating Vector Can Expand the A Bulge in the Encephalomyocarditis Virus Internal Ribosome Entry Site and Change Translation Efficiency of the Downstream Transgene

View more

Correction of Hyperbilirubinemia in Gunn Rats by Surgical Delivery of Low Doses of Helper-Dependent Adenoviral Vectors

View more

FAQS